Gloria Mas Martin

8PUBLICATIONS
51CO-AUTHORS
Tumour immunologyMedical mycologyRegenerative medicine (incl. stem cells)Medical devicesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 07, 2026
Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy.

|Jul 24, 2026
The NLRC4 Inflammasome Drives Myelodysplastic Syndrome by Linking Epigenetic Reprogramming and Innate Immune Signaling.

|Nov 24, 2025
Co-targeting menin and LSD1 dismantles oncogenic programs and restores differentiation in MLL-rearranged AML.

Mina M Tayari, Helena Gomes Dos Santos, Felipe Beckedorff

|Nov 24, 2025
Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy.

Erika Ciervo, Francesco Ceccarelli, Anna Maria Di Giacomo

|Apr 22, 2024
Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity.

Hidehiro Itonaga, Adnan K Mookhtiar, Sarah M Greenblatt

|Oct 31, 2019
TAF1 plays a critical role in AML1-ETO driven leukemogenesis.

Ye Xu, Na Man, Daniel Karl

Pageof 2

Frequent Collaborators

4 joint publications

Daniel Bilbao

2 joint publications

Francesco Ceccarelli

2 joint publications

Piera Grisolia

2 joint publications

Erika Ciervo